AI generated summary of Pubmed citation/abstract with PMID 38093174

https://pubmed.ncbi.nlm.nih.gov/38093174

A hypoxia-responsive prodrug that targets and disrupts the Golgi apparatus in tumor cells, when assembled into a nanoparticle with an anthracycline drug, shows improved efficacy in inhibiting tumor growth and metastasis.